Chemistry:1ZP2MA

From HandWiki

1ZP2MA, also known as [1-(indolizin-1-yl)propan-2-yl](methyl)amine or as 1-(indolizin-1-yl)-N-methylpropan-2-amine, is a monoamine releasing agent of the indolizinylethylamine family.[1] It is the analogue and positional isomer of the stimulant-like drug α,N-dimethyltryptamine (α,N-DMT or N-methyl-α-methyltryptamine (N-methyl-αMT)) in which the indole ring has been replaced with an indolizine ring.[1] 1ZP2MA has been found to be a potent dopamine releasing agent, with an EC50 of 62 nM.[1] It is the α-methyl and N-desmethyl analogue of (2-(indolizin-1-yl)ethyl)dimethylamine (TACT908; the indolizine analogue of dimethyltryptamine (DMT)).[1] 1ZP2MA and 2ZEDMA were patented by Tactogen in 2023.[1]

See also

References

  1. ↑ 1.0 1.1 1.2 1.3 1.4 Baggott MJ, "Indolizine compounds for the treatment of mental disorders or inflammation", WO patent 2023183613A2, published 2023 September 28, assigned to Tactogen



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:1ZP2MA&oldid=4175982"